Title : HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support.

Pub. Date : 2001 Apr

PMID : 11477443






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our results suggest that patients with metastatic breast cancer and high soluble plasma HER-2 have a significantly poorer overall (OS) and progression-free survival (PFS) following high-dose chemotherapy with paclitaxel and ASCT. asct erb-b2 receptor tyrosine kinase 2 Homo sapiens